TEVA PHARMACEUTICAL FIN LLC's ticker is and the CUSIP is 88163VAE9. A total of 52 filers reported holding TEVA PHARMACEUTICAL FIN LLC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $7,965,000 | -18.2% | 10,000,000 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $9,738,000 | -0.4% | 10,000,000 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $9,776,000 | +0.2% | 10,000,000 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $9,752,000 | -0.8% | 10,000,000 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $9,833,000 | -0.2% | 10,000,000 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $9,851,000 | -1.3% | 10,000,000 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $9,980,000 | +0.3% | 10,000,000 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $9,950,000 | +1.5% | 10,000,000 | -1.0% | 0.00% | 0.0% |
| Q3 2020 | $9,800,000 | +0.2% | 10,098,000 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $9,779,000 | +4.5% | 10,098,000 | -0.1% | 0.00% | 0.0% |
| Q1 2020 | $9,356,000 | +2718.1% | 10,108,000 | +2661.7% | 0.00% | – |
| Q3 2019 | $332,000 | -13.8% | 366,000 | -13.1% | 0.00% | – |
| Q2 2019 | $385,000 | -24.2% | 421,000 | -23.6% | 0.00% | – |
| Q1 2019 | $508,000 | +96.9% | 551,000 | +92.7% | 0.00% | – |
| Q4 2018 | $258,000 | -3.7% | 286,000 | 0.0% | 0.00% | – |
| Q3 2018 | $268,000 | +0.8% | 286,000 | 0.0% | 0.00% | – |
| Q2 2018 | $266,000 | -35.9% | 286,000 | -39.7% | 0.00% | – |
| Q1 2018 | $415,000 | -0.2% | 474,000 | 0.0% | 0.00% | – |
| Q4 2017 | $416,000 | -2.6% | 474,000 | 0.0% | 0.00% | – |
| Q3 2017 | $427,000 | -15.9% | 474,000 | 0.0% | 0.00% | – |
| Q2 2017 | $508,000 | 0.0% | 474,000 | 0.0% | 0.00% | – |
| Q1 2017 | $508,000 | -2.1% | 474,000 | 0.0% | 0.00% | – |
| Q4 2016 | $519,000 | +37.7% | 474,000 | +50.0% | 0.00% | – |
| Q3 2016 | $377,000 | -4.8% | 316,000 | 0.0% | 0.00% | – |
| Q2 2016 | $396,000 | -3.9% | 316,000 | 0.0% | 0.00% | – |
| Q1 2016 | $412,000 | -16.6% | 316,000 | 0.0% | 0.00% | – |
| Q4 2015 | $494,000 | -12.4% | 316,000 | -24.0% | 0.00% | – |
| Q3 2015 | $564,000 | -50.2% | 416,000 | -48.6% | 0.00% | – |
| Q2 2015 | $1,132,000 | -5.5% | 810,000 | 0.0% | 0.00% | – |
| Q1 2015 | $1,198,000 | – | 810,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ZAZOVE ASSOCIATES LLC | 91,833,000 | $98,950,000 | 5.16% |
| Ferox Capital Management LP | 5,390,000 | $5,796,000 | 2.37% |
| INCOME RESEARCH & MANAGEMENT | 7,472,000 | $8,014,000 | 2.17% |
| SPHERA FUNDS MANAGEMENT LTD. | 14,535 | $8,641,000 | 1.47% |
| Lombard Odier Asset Management (Europe) Ltd | 21,660,000 | $23,433,000 | 1.33% |
| SHENKMAN CAPITAL MANAGEMENT INC | 11,864,000 | $12,783,000 | 1.15% |
| MACKAY SHIELDS LLC | 18,887,000 | $20,335,000 | 0.86% |
| AEGON USA Investment Management, LLC | 4,000,000 | $4,290,000 | 0.84% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 32,751,000 | $35,196,000 | 0.67% |
| PALISADE CAPITAL MANAGEMENT, LP | 6,067,000 | $6,522,000 | 0.24% |